1492 Capital Management LLC Myriad Genetics Inc Transaction History

1492 Capital Management LLC

  • $164 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$26.93 - $34.7 $802,136 - $1.03 Million
-29,786 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$27.23 - $45.56 $58,735 - $98,272
-2,157 Reduced 6.75%
29,786 $866,000
Q3 2018

Nov 14, 2018
BUY
$37.57 - $50.34 $106,736 - $143,015
2,841 Added 9.76%
31,943 $1.47 Million
Q2 2018

Aug 14, 2018
BUY
$27.75 - $40.17 $236,763 - $342,730
8,532 Added 41.48%
29,102 $1.09 Million
Q1 2018

May 14, 2018
BUY
$28.83 - $41.01 $593,033 - $843,575
20,570 New
20,570 $608,000

Others Institutions Holding MYGN

# of Institutions
232
Shares Held
92.6M
Call Options Held
117K
Put Options Held
113K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.17B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email